Status:
COMPLETED
Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis
Lead Sponsor:
Guangdong Provincial Hospital of Traditional Chinese Medicine
Conditions:
Acute Gout Arthritis
Acupuncture
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the immediate analgesic effect and patients' evaluation of the treatment of cheek acupuncture in patients with acute gouty arthritis. The main question i...
Detailed Description
The symptoms of acute gouty arthritis (AGA) are extremely painful, but most patients do not begin to experience pain relief until after they have been seen by a doctor and have taken their medication,...
Eligibility Criteria
Inclusion
- Meet the diagnostic criteria for acute gouty arthritis and with attacks in the unilateral ankle or first metatarsophalangeal joint;
- Age ≥18 years old and ≤75 years old, regardless of gender; ③ The gouty arthritis attack is within 48h; ④ Without therapy with targeted topical treatment or self-administered medications including colchicine, anti-inflammatory pain medications, hormones, herbs, etc.
- Agreement to comply with the clinician's treatment plan.
Exclusion
- Pregnant or breast-feeding
- Patients with malignant tumors, severe dysfunction of the heart, liver, and kidneys, diabetes mellitus and hypertension
- Mental disorders that render the patient unable to understand the nature of the study, its scope, and possible outcomes or unable to follow the doctor's advice
- Allergic to the components of the drug in this study
- Patients with active peptic ulcers/bleeding, or previous recurrent ulcers/bleeding.
- History of asthma, urticaria or allergic reactions induced by taking aspirin or other non-steroidal anti-inflammatory drugs
- Congestive heart failure (New York Heart Association \[NYHA\] cardiac function class II-IV)
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06001112
Start Date
September 1 2023
End Date
December 31 2023
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yupinglin Lin
Guangzhou, Guangdong, China, 510120